Stay updated on Durvalumab Combo + Maintenance in Advanced Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combo + Maintenance in Advanced Ovarian Cancer Clinical Trial page.

Latest updates to the Durvalumab Combo + Maintenance in Advanced Ovarian Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe page's revision history was updated to add Revision: v3.4.3 and remove Revision: v3.4.2.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedRevision: v3.4.2 is now shown, replacing the previous v3.4.1.SummaryDifference0.0%

- Check30 days agoChange DetectedRevision: v3.4.1 introduced as part of the site update; no substantive changes to the page content or its functionality were observed.SummaryDifference0.0%

- Check38 days agoChange DetectedAdded: Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0; removed: Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.1%

- Check52 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4; no visible changes to content or layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check73 days agoChange DetectedAdded a centralized Locations section with entries for multiple US states and Canadian provinces, and removed the prior separate state/province location pages.SummaryDifference0.6%

Stay in the know with updates to Durvalumab Combo + Maintenance in Advanced Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combo + Maintenance in Advanced Ovarian Cancer Clinical Trial page.